Illumina Inc (ILMN)
117.31
+0.62
(+0.53%)
USD |
NASDAQ |
Apr 19, 16:00
117.31
0.00 (0.00%)
After-Hours: 20:00
Illumina Research and Development Expense (Quarterly): 341.00M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 341.00M |
| September 30, 2023 | 315.00M |
| June 30, 2023 | 358.00M |
| March 31, 2023 | 341.00M |
| December 31, 2022 | 346.00M |
| September 30, 2022 | 325.00M |
| June 30, 2022 | 327.00M |
| March 31, 2022 | 323.00M |
| December 31, 2021 | 350.00M |
| September 30, 2021 | 436.00M |
| June 30, 2021 | 202.00M |
| March 31, 2021 | 197.00M |
| December 31, 2020 | 199.00M |
| September 30, 2020 | 172.00M |
| June 30, 2020 | 155.00M |
| March 31, 2020 | 156.00M |
| December 31, 2019 | 161.00M |
| September 30, 2019 | 151.00M |
| June 30, 2019 | 166.00M |
| March 31, 2019 | 169.00M |
| December 31, 2018 | 176.00M |
| September 30, 2018 | 159.00M |
| June 30, 2018 | 151.00M |
| March 31, 2018 | 137.00M |
| December 31, 2017 | 137.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 134.00M |
| June 30, 2017 | 130.00M |
| March 31, 2017 | 145.00M |
| December 31, 2016 | 130.00M |
| September 30, 2016 | 126.00M |
| June 30, 2016 | 125.00M |
| March 31, 2016 | 124.00M |
| December 31, 2015 | 113.82M |
| September 30, 2015 | 99.23M |
| June 30, 2015 | 96.18M |
| March 31, 2015 | 91.77M |
| December 31, 2014 | 142.95M |
| September 30, 2014 | 85.08M |
| June 30, 2014 | 82.98M |
| March 31, 2014 | 77.04M |
| December 31, 2013 | 76.73M |
| September 30, 2013 | 70.96M |
| June 30, 2013 | 67.61M |
| March 31, 2013 | 61.45M |
| December 31, 2012 | 56.91M |
| September 30, 2012 | 54.06M |
| June 30, 2012 | 71.22M |
| March 31, 2012 | 48.84M |
| December 31, 2011 | 45.51M |
| September 30, 2011 | 50.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
151.00M
Minimum
Sep 2019
436.00M
Maximum
Sep 2021
264.26M
Average
315.00M
Median
Sep 2023
Research and Development Expense (Quarterly) Benchmarks
| Exact Sciences Corp | 114.92M |
| Guardant Health Inc | 89.86M |
| Mettler-Toledo International Inc | 46.44M |
| Natera Inc | 82.96M |
| Castle Biosciences Inc | 12.99M |